A new report - developed by R-Health Consult and commissioned for EFPIA - provides an analysis of the economic and health benefits of investment in five key non-communicable diseases (NCDs).
The research looks at stroke, ischaemic heart disease, type 2 diabetes, chronic obstructive pulmonary disease (COPD), and breast cancer across the 27 European Union Member States and makes recommendations on how to reduce mortality, improve quality of life for patients while improving return on investments (ROI) for the European economy.
It shows that substantial ROI can be made from targeted health interventions; it uses specific insights from case studies in three countries - Portugal, Romania, and Sweden.
